Broadfin Capital, LLC - IDERA PHARMACEUTICALS INC ownership

IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 108 filers reported holding IDERA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of IDERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2017$4,285,000
-20.9%
2,030,604
-16.4%
0.70%
-12.7%
Q3 2017$5,419,000
-18.2%
2,429,937
-36.9%
0.80%
-0.4%
Q2 2017$6,627,000
-30.4%
3,852,9450.0%0.80%
-30.2%
Q1 2017$9,517,000
+43.3%
3,852,945
-13.0%
1.15%
+56.4%
Q4 2016$6,642,000
+6.9%
4,427,745
+82.4%
0.74%
+32.3%
Q3 2016$6,215,000
+31.3%
2,427,745
-21.6%
0.56%
+21.1%
Q2 2016$4,735,000
-22.7%
3,094,7450.0%0.46%
-22.3%
Q1 2016$6,128,000
-35.9%
3,094,7450.0%0.59%
+0.7%
Q4 2015$9,563,000
-45.3%
3,094,745
-40.6%
0.59%
-39.5%
Q3 2015$17,467,000
-16.9%
5,213,979
-7.9%
0.97%
-13.9%
Q2 2015$21,013,0000.0%5,663,8450.0%1.13%
-31.0%
Q1 2015$21,013,000
-32.4%
5,663,845
-19.7%
1.64%
+21.1%
Q4 2014$31,096,000
+285.1%
7,051,400
+100.0%
1.35%
+59.6%
Q3 2014$8,074,000
-60.5%
3,525,700
-50.0%
0.85%
-15.8%
Q2 2014$20,450,000
+56.6%
7,051,400
+120.3%
1.01%
-20.5%
Q1 2014$13,059,000
-20.6%
3,200,700
-9.8%
1.26%
-41.7%
Q4 2013$16,437,000
+108.8%
3,550,000
-21.5%
2.17%
+55.1%
Q3 2013$7,874,0004,525,0001.40%
Other shareholders
IDERA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,200,700$13,059,0001.26%
Cormorant Asset Management, LP 400,000$1,632,0000.38%
NATIXIS 3,149,116$12,849,0000.17%
WALL STREET ASSOCIATES 500,000$2,040,0000.17%
GUARDIAN LIFE INSURANCE CO OF AMERICA 371,759$1,517,0000.14%
CARL DOMINO INC 45,137$184,0000.10%
HOLLENCREST CAPITAL MANAGEMENT 142,000$580,0000.09%
Baker Brothers Advisors 1,613,076$6,581,0000.08%
LEAVELL INVESTMENT MANAGEMENT, INC. 81,271$332,0000.06%
MARSHALL WACE, LLP 572,305$2,335,0000.04%
View complete list of IDERA PHARMACEUTICALS INC shareholders